Six months ended June 30, | ||||||
In millions of Euros | 2018 IFRS | Adjustment | 2018 Non-IFRS | |||
Cost of revenue | (240.2) | 2.1 | (238.1) | |||
Research and development | (314.0) | 23.1 | (291.0) | |||
Marketing and sales | (515.8) | 13.9 | (501.9) | |||
General and administrative | (139.6) | 21.1 | (118.4) | |||
Total share-based compensation expense | € 60.2 |
(2) The non-IFRS percentage increase (decrease) compares non-IFRS measures for the two different periods. In the event there is non-IFRS adjustment to the relevant measure for only one of the periods under comparison, the non-IFRS increase (decrease) compares the non-IFRS measure to the relevant IFRS measure.
(3) Based on a weighted average 260.0 million diluted shares for H1 2018 and 257.1 million diluted shares for H1 2017.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180724005955/en/